Australia’s major banking, retail and manufacturing brands are often regarded as less interested in the aggressive overseas expansion being pursued by market leaders in other countries. Some have tried – with mixed success. Catherine Welch explains.
Read More
Risky business: the human cost of outsourcing drug production
Outsourcing used to happen on an ad hoc basis, when big pharmaceutical companies were short of capacity. But in the past decade, outsourcing has become a central strategy.
Read More
Read More